(U//LES) DEA Bulletin: Fake Xanax Tablets Containing Cyclopropylfentanyl, Methamphetamine, and FUB-AKB48

November 25, 2018

The following DEA bulletin was obtained from the public website of a regional law enforcement organization.

Emerging Trend: Fake Xanax Tablets Containing Cyclopropylfentanyl, Methamphetamine, and FUB-AKB48

Page Count: 2 pages
Date: August 2018
Restriction: Law Enforcement Sensitive, DEA Sensitive
Originating Organization: Drug Enforcement Administration, Phoenix Field Division
File Type: pdf
File Size: 757,756 bytes
File Hash (SHA-256): 26CF9A0FF6FABD34597AFE24C4E79529AC8BEC47461ABB62B2A2F79322D99ACE

Download File

(U//DSEN/LES) The increasing demand for opioids in the United States coupled with the availability of fentanyl presents a significant public health risk and negatively impacts officer safety. In 2018, the Arizona High Intensity Drug Trafficking Area (HIDTA) Counter Narcotics Alliance (CNA) task force seized tablets that appeared to be Xanax® but actually contained a combination of cyclopropylfentanyl, methamphetamine, and a synthetic cannabinoid chemical.

(U) Significance

(U//LES) This is the first seizure reported to the Arizona HIDTA of fake Xanax® tablets containing a cyclopropylfentanyl/methamphetamine combination, as well as being the first reported seizure containing a synthetic cannabinoid.

(U) Details

(U) Fake Xanax® Tablets

(U//LES) An investigation conducted by the Arizona HIDTA CNA task force resulted in the seizure of two plastic bags containing 76 rectangular white tablets imprinted with “XANAX” on one side and the number “2” on the reverse side. The tablet imprints and color were consistent with pharmaceutically manufactured 2 milligram Xanax® tablets. Upon closer examination, the tablets varied in thickness and from white to off-white in color. In addition, some of the tablets had an inverted “2” imprinted on the reverse side.